Eurotransplant Annual Meeting 2015
There is a substantial difference in the donor and recipient population when comparing Europe and SA. In SA the donors are
younger, of a larger spread in ethnical descent, more often HIV positive (tested by p24, NAT and antigens) and more often
become donor candidates due to trauma. Furthermore, there often is an absence of medical history in the donors and most
of the recipients have not developed resistance to ART (antiretroviral therapy) as they have never received ART. The
recipients are also on average younger, have a higher percentage of HIV positivity and are transplanted due to HIV
nephropathy.
The interactive question at the beginning of the session was if HIV donors should be considered in Europe. The majority
agreed. At the end of the session the same question was posed, still with majority agreement.
The ET future of donor characterization: structured documentation
of technical investigations for improved quality and safety
Dr. Fischer-Fröhlich explains the history and the goals of the project
C OLD (Classification of Language Donor Information). An extensive
explanation is given on how donor characterization will take place in
the future based on a tick-box method. The main goal of project COLD
is to tackle the language issue within ET and optimize donor
characterization by standardization. This future idea will be included
in the next edition of the European Councils “Guide to Quality and
Safety of Organ for Transplantation”. The beginning of implementation
will take place with priority in 2016 along with the implementation of new ENIS.
What's new; developments in organ donation and follow-up
Dr. Marks gives a presentation on the most recent and important
developments for the OPC. With regard to the three main EU Directive
topics the OPC has taken steps to further develop these main topics in the
ET area; (1) donor characterization: Project COLD, (2) traceability:
Discarded Organs Application and a (3) preliminary reporting system for
Serious Adverse Events / Reaction (SAE/R). Other adaptations will take
place with regard to CMV testing for the heart/lung match and the
registration of allergies in the donor history.
Ethical Session
Mr. Bos and Dr. Cransberg present the “Ethical dilemmas in donation and
transplantation involving mentally incompetent children and adults”. Mr.
Bos focused on the donation side and Dr. Cransberg on the transplantation
side for both living and post-mortem donation.
Both the donation and transplantation sides have in common that they
focus on a more vulnerable population group. Within Europe, per ET
member state, there is different legislation and a difference in the donation
system (opt-in versus opt-out). Getting more specific numbers and an
Report Annual Meeting 2015 | Eurotransplant
15